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Abstract
The human Miro GTPases (hMiros) have recently emerged as important mediators of mitochondrial transport and may 
significantly contribute to the development of disorders such as Alzheimer’s and schizophrenia. The hMiros represent two 
highly atypical members of the Ras superfamily, and exhibit several unique features: the presence of a GTPase domain at 
both the N-terminus and C-terminus, the presence of two calcium-binding EF-hand domains and localisation to the mitochon-
drial outer membrane. Here, elucidation of Miro GTPase signalling pathway components was achieved through the use of 
molecular biology, cell culture techniques and proteomics. An investigation of this kind has not been performed previously; 
we hoped, through these techniques, to enable the profiling and identification of pathways regulated by the human Miro 
GTPases. The results indicate several novel putative interaction partners for hMiro1 and hMiro2, including numerous proteins 
previously implicated in neurodegenerative pathways and the development of schizophrenia. Furthermore, we show that the 
N-terminal GTPase domain appears to fine-tune hMiro signalling, with GTP-bound versions of this domain associated with 
a diverse range of interaction partners in comparison to corresponding GDP-bound versions. Recent evidences suggest that 
human Miros participate in host–pathogen interactions with Vibrio Cholerae type III secretion proteins. We have undertaken 
a bioinformatics investigation to identify novel pathogenic effectors that might interact with Miros.
Keywords Miro1 · Miro2 · Atypical GTPase · Mitochondrial function · Proteomics · Neurodegeneration · RhoC · Type III 
secretion system · VopE · Endoplasmic reticulum signalling
Abbreviations
ACN  Acetonitrile
FDR  False discovery rate
GO  Gene ontology
hMiro  Human Miro GTPase
PBS  Phosphate buffered saline
PSM  Peptide-to-spectrum match
Introduction
The Ras superfamily of small guanosine triphosphatases 
(GTPases), named after one of the most extensively studied 
oncogenes in human carcinogenesis, Ras, comprises over 
150 distinct human members across six sub-families: Ras, 
Rho, Rab, Ran, Arf and Miro. Typically, these so-called 
‘small’ GTPases are monomeric in nature, containing 
a canonical ~ 21 kDa catalytic ‘G domain’ [1, 2]. This G 
domain enables the hydrolytic degradation of GTP to GDP 
and is central to the function of Ras superfamily enzymes, 
enabling them to act as binary molecular switches within a 
diverse range of signalling pathways [3, 4]. Typically, these 
GTPases are ‘on’ (able to activate downstream signalling 
pathways) when GTP bound, and correspondingly ‘off’ 
(unable to activate downstream signalling pathways) when 
GDP bound, with this switch between ‘on’ and ‘off’ states 
tightly regulated by distinct groups of modulatory enzymes.
Initially characterised as atypical Rho GTPases [1], the 
Miro GTPases (‘mitochondrial Rho GTPases’) are so unu-
sual that it is now considered appropriate to classify them 
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into a separate sub-family: the Miro sub-family [2–4]. The 
Miro GTPases are evolutionarily conserved and first evo-
lutionally appear in yeast [5, 6], with two genes encoding 
Miro GTPases present in humans: hMiro1 and hMiro2 (also 
referred to as RhoT1 and RhoT2). Both human Miros consist 
of 618 amino acid residues, sharing 60% amino acid identity 
[1]. As schematically illustrated in Fig. 1, the Miro GTPases 
are composed of two GTPase domains flanked by a pair of 
 Ca2+-binding EF hand domains [1, 3, 5, 7–9]. Anchored to 
the mitochondrial outer membrane (MOM) by means of a 
C-terminal transmembrane sequence [10], the Miro proteins 
are accessible to the cytoplasm, where they act in an adap-
tor complex for mitochondrial movement and appear to be 
involved in a variety of mitochondrial-related processes 
including mitochondrial transportation, motility, morphol-
ogy and homeostasis [7, 11–14].
Pioneering work in mammalian cell lines functionally 
implicated the hMiros in apoptotic pathways and mitochon-
drial dynamics. Later, abrogation of the single Miro homo-
logue in Drosophila (dMiro) produced flies with small larvae 
size exhibiting symptoms associated with motor neurone 
disease: progressive locomotor defects culminating in early 
death. The effects of dMiro ablation were corrected upon 
reconstitution of neuronal dMiro, albeit not muscular dMiro, 
indicating a distinct importance for the Miro GTPases in 
neuronal health and pathogenesis. This link was reinforced 
by subsequent studies in mice and mammalian neuronal cell 
culture, showing that mitochondrial movement was severely 
impaired in neuronal cells upon Miro knockdown, and that 
Miro appeared necessary for correct prenatal innervation 
of the lungs during development in mice. Furthermore, 
several interaction partners for the mammalian Miros have 
recently been identified that implicate these remarkable 
enzymes in several serious pathologies including cancer, 
Parkinson’s disease (PD), Alzheimer’s disease (AD), ALS 
and schizophrenia.
Recent scientific investigations have clearly identified 
Miros’ influence on cell migration and proliferation through 
suppression of SMAD4 in pancreatic cells [15]. When chro-
mosome partitioning and organelle segregation were studied, 
it was clearly shown that mitotic distribution of the mito-
chondrial network was mediated by Miro along with Cenp-
F. Further Vibrio cholerae Type 3 secretion system effector 
VopE that localises to mitochondria during infection has 
been shown to act as a specific GTPase-activating protein 
to interfere with the function of mitochondrial Rho GTPases 
Miro1 and Miro2 [16].
Although Miro interaction partners continue to emerge, to 
our knowledge no high-throughput mass spectrometry-based 
proteomic analyses have been performed to evaluate the 
effects of the hMiro GTPase domain states on intracellular 
signalling pathway activities. The effect of the hMiro1 and 
hMiro2 N-terminal GTPase domain state produces distinct 
phenotypes visible through microscopy, though proteomic 
changes associated with these phenotypes have not been 
explored. A more complete understanding of the proteins 
expressed under constitutively active or dominant negative 
Miro N-terminal GTPase domain would serve as a valu-
able resource for understanding if, and how, this GTPase 
domain may influence or fine-tune intracellular signalling 
pathways. Towards this aim, we used a high-resolution 
accurate—mass Q-Exactive™ Hybrid Quadrupole-Orbit-
rap Mass Spectrometer to perform proteomic analyses of 
mammalian COS7 cells manipulated to overexpress either 
hMiro1 or hMiro2 N-terminal GTPase mutants. We identi-
fied hundreds of proteins for the first time unique to each 
test condition. When cross-referenced against bioinformati-
cal resources, 13 unique proteins of interest were identified 
for hMiro1 signalling and 24 unique proteins of interest were 
identified for hMiro2 signalling. The results provide a proof-
of-concept for studying Miro GTPase signalling pathways 
in this manner, suggesting that the state of the N-terminal 
GTPase domain is able to fine tune Miro signalling in mam-
malian cells.
Results and discussion
LC-MS/MS analysis of control, V13 (constitutively active 
at the N-terminal GTPase domain) and N18 (dominant 
negative at the N-terminal GTPase domain) hMiro1 and 
hMiro2 samples resulted in the identification of the fol-
lowing numbers of unique proteins associated with each 
condition: 693 (control), 506 (hMiro1 V13), 429 (hMiro1 
N18), 644 (hMiro2 V13) and 855 (hMiro2 N18). Of these 
proteins, more than 80% were identified with multiple pep-
tides successfully matched. Complete lists of the peptides 
and proteins are provided in the ESI Table S1. We com-
pared the proteomic data with protein–protein interaction 
predictions obtained from the STRING 2.0 protein–protein 
Fig. 1  Schematic diagram of hMiro1 and hMiro2 GTPase domain architecture. Amino and carboxy terminus of the open reading frame shown 
using N and C. The transmembrane region responsible for localising to the mitochondrial outer membrane is depicted as TM
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interaction prediction database, which integrates several 
different prediction algorithms, in addition to automated 
literature mining and surveying curated databases of known 
interactors, to generate networks of known and predicted 
protein interactors for defined protein entries. Additionally, 
we compared our proteomic data to known Miro interac-
tors defined by manual literature searches, and by STRING 
2.0 outputs for the three closest homologues of hMiro1 
and hMiro2. The outputs for STRING 2.0 and the manual 
literature data are provided in the ESI. When results were 
cross-referenced against all bioinformatic sources, 13 unique 
proteins associated with hMiro1 mutants were identified (3 
for V13 and 10 for N18 mutants) and 24 unique proteins 
associated with hMiro2 mutants were identified (for 6 V13 
and 18 for N18 mutants), as shown in Figs. 2 and 3, respec-
tively. Lists of these unique proteins are provided as Table 1 
(hMiro1) and Table 2 (hMiro2). Analysis of the differentially 
expressed proteins clearly shows involvement of Miros in 
cellular processes such as mitochondrial movement, neu-
ronal enriched proteins, ER related and developmentally 
implicated proteins that are reported in literature in varying 
extent. Conversely, very novel cellular processes such as pro-
tein expression, endocytosis, various metabolic processes, 
nucleotide biosynthesis apoptosis and Anaemia-related class 
of proteins are absolutely novel. A more detailed chart, dis-
playing the function of proteins associated with either the 
V13 (constitutively active) or N18 (dominant negative) ver-
sions of hMiro1 and hMiro2, is shown in Fig. 5.
hMiro1 and hMiro2 may be involved in distinct, 
but related, signalling pathways
The proteomic changes based on hMiro constructs trans-
fection were analysed. The results show hMiros participat-
ing in a number of cellular function mediated by human 
Miros outside the mitochondrial functions. These are the 
Fig. 2  Number of proteins 
identified for each hMiro1 con-
dition, cross-referenced against 
bioinformatics sources. The 
differentially expressed proteins 
identified for Miro1 constitu-
tively active V13 and dominant 
negative N18 mutants against 
the control is given which is 
cross referenced with STRING 
bioinformatics tool. This is 
further cross referenced with 
literature reported and Miro 
homologues in lower organ-
isms. The total differentially 
expressed proteins identified by 
fold change are given in each 
of the arm and the overlapping 
number of proteins between 
each species is also given
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overlapping functions of both hMiros where the enzymes 
in its GTP-bound active state can bind to a number of 
effectors or mediate a number of cellular processes through 
influencing the proteome of the cell thereby participating 
in a number of signalling events. The results show hMi-
ros participating in a number of cellular function outside 
mitochondrial transport. When the biological functions of 
the proteins interacting with hMiros were analysed it was 
evident that proteins involved in neuronal function, pro-
teasome-mediated functions including degradation, vesicle 
transport/ endocytosis, various metabolic and develop-
mental processes were interacting with both hMiro1 and 
hMiro2. These are the overlapping functions of both hMi-
ros where the GTPase in its GTP-bound active state can 
bind to a number of effectors involved in these processes. 
The differentially expressed proteins that were observed in 
both hMiro1 and hMiro2 active mutants show several pro-
teasomal function genes. For hMiro1 this included many 
proteosomal proteins including threonyl-TRNA synthetase 
like 2 (TARSL-2), ribosomal protein lateral stalk subunit 
P0 pseudogene 6 (RPLP0P6), COP9 signalosome subunit 
4 (COSP4), RNA-binding motif protein (RBM3), proteo-
some subunit alpha 2 (PSMA2) and neuronal precursor 
cell expressed developmentally downregulated 4, E3 ubiq-
uitin protein ligase (NEDD4) (see section below), while 
Miro2 constitutively active mutants also show differences 
in the expressions of proteosome subunit beta1 (PSMB1), 
paraspeckle component 1 (PSPC1), ubiquitin-like modifier 
activating enzyme2 (UBA2), ribosomal protein S27 like 
(RPS27L), proteosome subunit alpha2 (PSMA2) amongst 
others. It is therefore evident that both hMiros cause dif-
ferential expression of the proteosome synthesis, ubiqui-
tin-mediated degradation and other proteosomal remod-
elling component entities when overexpressed in cells. 
It is important to understand that although overlapping 
pathways are identified in hMiros function, the cellular 
Fig. 3  Number of proteins 
identified for each hMiro2 
condition, cross-referenced 
against bioinformatics sources. 
The differentially expressed 
proteins identified for Miro2 
constitutively active V13 mutant 
and dominant negative N18 
mutants against the control are 
given which are cross refer-
enced with STRING bioinfor-
matics tool. This is further 
cross referenced with literature 
reported and Miro homologues 
in lower organisms. The total 
differentially expressed proteins 
identified by fold change is 
given in each of the arm and the 
overlapping number of proteins 
between each species is also 
given
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mediators are different depending on the specific hMiro 
in action.
When we analysed whether the two different human 
Miros interacted with exclusive effectors or protein-binding 
partners, we did identify some distinct cellular function and 
pathways for hMiro1 and hMiro2. The hMiro1 mediates 
cytoskeletal remodelling (see Figs. 4, 5) possibly through 
tubulin beta 2A (TBB2A_human), actin alpha 1 (ACTN1), 
actin-related protein 3 homolog (ACTR3), capping actin 
protein of muscle Z-line alpha subunit1 (CAPZA1), tropo-
modulin (TMOD3) and mediator of cell motility (MEMO1). 
However, existing literature studies already suggest the role 
of hMiros in mitochondrial transport through the actin 
cytoskeletal pathway. It is important to note that the pro-
teins involved in transport machinery component, cytoskel-
etal reorganisation and mitochondrial movement may not 
be mutually exclusive and it is very likely that they are 
interconnected by function based on the cellular status. As 
previously stated, very little is known regarding hMiro2 
cellular function in general. Therefore, we do not currently 
have any idea of the signalling cascade, interaction partner 
and GTPase effectors of hMiro2. Various novel processes 
that are potentially mediated by hMiro2 came to light when 
we analysed the proteome profile of constitutively active 
hMiro2. This revealed that hMiro2 could be exclusively 
mediated by cell cycle/cell growth function, which would 
relate to cancer and apoptotic functions (see Figs. 4, 5). The 
processes of cell death, apoptosis, cell growth and cell cycle 
regulation could be mediated by hMiro2 through proteins 
including G3BP stress granule assembly factor 1(G3BP1), 
heterogeneous nuclear ribonucleoprotein U (HNRNPU) 
nutrix hydrolase 21 protein CPSF5, nitralase family mem-
ber 2 (NIT2), multifunctional protein tetratricopeptide repeat 
domain 38 (TTC38) and acyl-coA-binding domain contain-
ing 3 (ACBD3). It is of note that several genes involved in 
gene expression control such as non-POU domain containing 
octomer binding (NONO), histone deacetylase (HDAC1), 
minichromosome maintenance complex component 2 
Table 1  Identification of 13 proteins of interest related to hMiro1 signalling
Identifier Protein function STRING score
Miro1V13(+)/STRING
 GPAT, ATASE, PRAT Regulatory allosteric enzyme; catalyses the first step of de novo purine nucleo-
tide biosynthetic pathway
0.999
 SUMO3, HSMT3, smt3A Member of the small ubiquitin-related modifier (SUMO) family; becomes 
covalently conjugated to other proteins via post-translation sumoylation
0.999
Miro1V13(+)/STRING/homology
 NEDD4-1, RPF1, KIAA0093 E3 ubiquitin protein ligase expressed in neuronal precursor cells; developmen-
tally downregulated in the early central nervous system
0.999
Miro1N18(−)/STRING
 EF2, EEF-2, SCA26, EF-2 Member of the GTP-binding translation elongation factor family; facilitates 
GTP-dependent ribosomal translocation during protein synthesis
0.999
 B-ALPHA-1, FLJ25113 Major microtubule component displaying enriched expression in morphologi-
cally differentiated neuronal cells
0.986
 Cortactin, EMS1 Promotes polymerisation and rearrangement of the actin cytoskeleton when 
stimulated by external stimuli
0.985
 RAB11A Controls intracellular trafficking of the innate immune receptor TLR4. May 
facilitate protein trafficking. Associated with secretory pathways
0.984
 Nedd-8, NEDD-8 E3 ubiquitin protein ligase expressed in neuronal precursor cells; developmen-
tally downregulated in the early central nervous system
0.976
 EPF5, E2EPF, E2-EPF Ubiquitin conjugating enzyme E2 for targeting of proteins for proteasomal 
degradation
0.973
Miro1N18(−)/homology
 SMMHC, KIAA0866, AAT4, SMHC, FAA4 Myosin heavy chain 11; major contractile protein. Converts chemical energy 
into mechanical energy through ATP hydrolysis
N/A
Miro1N18(-)/STRING/homology
 RhoC, ARHC, RHOH9 Stimulates reorganisation of the actin cytoskeleton and regulates cell shape, 
attachment, and motility
0.973
 PSMD4, pUB-R5, AF-1 Non-ATPase subunit of the 19S regulator lid of the 26S proteasome 0.972
Miro1N18(−)/literature
 Centromere protein F, PRO1779, CENPF Protein that associates with the centromere-kinetochore complex; facilitates 
mitochondrial movement during cytokinesis
N/A
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Table 2  Identification of 24 proteins of interest related to hMiro2 signalling
Identifier Protein function STRING score
Miro2V13(+)/STRING 0.999
 PDHE1-B, PDHBD, PHE1B E1 alpha 1 sub-unit of the pyruvate dehydrogenase (PDH) 
complex; catalyses overall conversion of pyruvate to acetyl-
CoA and  CO2. Mutations in this gene are associated with 
pyruvate dehydrogenase E1-alpha deficiency and X-linked 
Leigh syndrome
0.999
 MC5DN4, COXPD22, ATP5A, ATPM, MOM2, OMR, 
hATP1, ATP5AL2, ORM, HEL-S-123m
ATP synthase, H + transporting, mitochondrial F1 complex, 
alpha subunit 1; catalyses ATP synthesis during oxidative 
phosphorylation
0.999
 PSC5, HC5, PMSB1 Proteasome subunit beta 1. Component of the proteasome 
core; tightly linked to TBP (TATA-binding protein)
0.999
 HDH-VIII, G3BP G3BP stress granule assembly factor 1; facilitates DNA 
unwinding and acts as a signalling element of the Ras path-
way, binding specifically to RasGAP
0.999
 S12, P40, MOV34, MOV34L, Rpn8 A non-ATPase subunit of the 19S proteasome regulator lid of 
the 26S proteasome complex
0.999
 EPS15R, eps15R Epidermal growth factor receptor pathway substrate; constitu-
tive component of clathrin-coated pits that is required for 
receptor-mediated endocytosis. Involved in cadherin binding 
associated with cell–cell adhesion
0.999
Miro2N18(−)/STRING
 S16 Ribosomal protein S16, a protein component of the 40S sub-
unit
0.999
 ERO1LA, Ero1alpha, ERO1-L, ERO1-L-alpha, ERO1L, 
ERO1-alpha
Endoplasmic reticulum oxidoreductase 1 alpha; an oxidis-
ing enzyme that exists in the endoplasmic reticulum and is 
induced under hypoxia
0.962
 EIEE31, DNM Member of the dynamin subfamily of GTP-binding proteins, 
involved in tubulation and severing of membranes and asso-
ciated with clathrin-mediated endocytosis and other vesicular 
trafficking processes
0.942
 HUWE1, KIAA1578, KIAA0312, MULE, LASU1, UREB1, 
URE-B1, Ib772, ARF-BP1, HECTH9, HSPC272
E3 ubiquitin ligase known to ubiquitinate the anti-apoptotic 
protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-
related)). This protein also ubiquitinates the p53 tumour 
suppressor, core histones and DNA polymerase beta
0.9
 VPS23, TSG10 Apparently inactive homolog of ubiquitin-conjugating 
enzymes. May act as a negative growth regulator. Appears 
important for genomic stability and cell cycle regulation
0.867
 PTPN1, PTP1B A founding member of the protein tyrosine phosphatase (PTP) 
family. Catalyses the hydrolysis of the phosphate monoesters 
specifically on tyrosine residues
0.818
 hUba3, hUBA3, NAE2, UBE1C Member of the E1 ubiquitin-activating enzyme family; associ-
ates with AppBp1, an amyloid beta precursor protein binding 
protein, to form a heterodimer, subsequently activating 
NEDD8, a ubiquitin-like protein, which regulates cell divi-
sion, signalling and embryogenesis
0.81
 RAP1A, RAP1, SMGP21, C21KG, KREV-1, G-22K, 
KREV1
Counteracts the mitogenic function of RAS through its ability 
to interact with RAS GAPs and RAF in a competitive man-
ner
0.726
 KIAA1794, FLJ10719 Fanconi anaemia complementation group I, associated with 
Fanconi anaemia
0.651
 Active BCR-related, MDB Contains a GTPase-activating protein domain; appears to play 
a role in vestibular morphogenesis
0.472
 UBCH7, E2-F1, L-UBC, UbcM4, UBCE7 Member of the E2 ubiquitin-conjugating enzyme family 
known to facilitate the ubiquitination of p53, c-Fos and the 
NF-kB precursor p105 in vitro
0.471
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(MCM2), H3 histone family member (H3F3C) are also 
differentially expressed due to hMiro2 constitutive overex-
pression. These genes may regulate the downstream mRNA 
expression of other genes that control previously unspecified 
cellular functions.
Of the proteins of interest identified, three were par-
ticularly noteworthy: RhoC, rUB-R5 and NEDD4. These 
proteins were identified as potential interactors across three 
separate search mechanisms, including experimental analy-
sis, homology studies and the extensive database searches 
performed by STRING. NEDD4 was linked to hMiro1-V13 
overexpression, while RhoC and PSMD4 were associated 
with hMiro1-N18 over-expression. All 3 of these proteins 
possessed functions that showed an enriched presence in 
the other proteins of interest, namely the reorganisation of 
the cytoskeleton (RhoC, NEDD4), neuronal cell involve-
ment (NEDD4) and links to ubiquitin-mediated proteasomal 
degradation (NEDD4, PSMD4). However, several groups of 
proteins identified were also of particular interest, including 
the clusters related to neuropathological disorders.
Neuronal precursor developmentally 
downregulated (NEDD) proteins
The NEDD proteins were originally identified as ‘neural 
precursor cell expressed, developmentally downregulated’ 
proteins. Other than NEDD4, several other identified pro-
teins were NEDD proteins (NEDD6, NEDD8) or proteins 
found to act within NEDD-related pathways (hUba3, Ras, 
AppB1). This implies a role for hMiros in neuronal signal-
ling associated with proteins that are commonly downregu-
lated in neuronal precursor cells. Intriguingly, NEDD4 was 
the only neurone-related protein to be associated with a V13 
mutant; all of the other neuronally enriched proteins iden-
tified were associated with N18 hMiro mutants, suggest-
ing that the status of the N-terminal GTPase domain may 
be important in mediating neuronally enriched signalling 
pathways. Indeed, while the NEDD proteins were originally 
identified as ‘neural precursor cell expressed, developmen-
tally downregulated’ proteins, these proteins are frequently 
functionally diverse and do not necessarily occur within the 
same signalling pathways. Thus, while a GTP-bound ver-
sion of the N-terminal GTPase domain may influence one 
pathway, a change of status to the GDP-bound version may 
influence another.
NEDD4 itself is classified as an E3 ubiquitin ligase local-
ised to the cytoplasm, and has been demonstrated to mediate 
a range of important cellular processes including neuronal 
development, cellular growth and intracellular homeosta-
sis [17]. NEDD4 functions through ubiquitination ligase 
activity and other mechanisms which are not fully under-
stood. However, it has been established that NEDD4 can 
be activated by a variety of signalling molecules, and that 
auto-inhibition can occur in the absence of calcium [18]. 
Intriguingly, all of the NEDD-related proteins are develop-
mentally downregulated in neuronal cells and many appear 
to play roles in normal development of the nervous system 
[19]. Similar functions have been noted for mammalian 
Table 2  (continued)
Identifier Protein function STRING score
 HEL-S-70p, PURH, AICAR, IMPCHASE, AICARFT Acts as a 5-aminoimidazole-4-carboxamide ribonucleotide 
formyltransferase/IMP cyclohydrolase; enhances the rate 
of nucleotide re-synthesis, increasing adenosine genera-
tion from adenosine monophosphate during conditions of 
myocardial ischemia
0.466
 L23A, MDA20 Ribosomal protein L23a; may be one of the target proteins 
involved in mediating growth inhibition by interferon
0.999
 L10A, Csa-19, CSA19, NEDD6 Ribosomal protein downregulated in neural precursor cells 
during development
0.999
 Calnexin, CNX, IP90, P90 Calcium-binding, endoplasmic reticulum (ER)-associated 
protein; interacts transiently with newly synthesized N-linked 
glycoproteins, facilitating protein folding and assembly. Pos-
sible roles in facilitating protein folding and quality control
0.999
 PTER, HPHRP, RPR-1 Phosphotriesterase-related protein; may be involved in regula-
tion of mitosis and transport of proteins to the cell surface
0.774
 CIP75, A1U, C1orf6, A1Up, UBIN Ubiquilin 4; involved in regulation of protein degradation via 
the ubiquitin–proteasome system (UPS)
0.774
Miro2N18(−)/homology
 CASP3, CPP32B, SCA-1, CPP32, Yama, apopain Associated with apoptotic signalling. Cleaves and activates 
caspases 6, 7 and 9. Is the principal caspase involved in the 
cleavage of amyloid-beta 4A precursor protein (a protein 
associated with neuronal death in Alzheimer’s disease)
N/A
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and fly Miro, with homozygous  Miro1−/− ablation in mice 
resulting in dysfunctional neuronal developmental, most 
critically resulting in incomplete lung innervation [20]. It 
is possible that the mammalian Miros may act within path-
ways that regulate NEDD4 activity, and that disruption of 
Miros during development prevents adequate downregula-
tion of NEDD4 and other NEDD proteins. Conversely, a 
functional link between these proteins during development 
may not exist, and the hMiros could represent a ubiquit-
ination target for NEDD4. Further experimental work is 
required to explore these possibilities. Curiously, NEDD4 
has also been implicated in schizophrenia [21], a serious 
psychiatric condition commonly presenting with delusions, 
hallucinations and profound disturbances in cognition and 
emotion [22]. This is in congruence with the hMiro1, which 
has been previously linked to schizophrenia through inter-
action with the DISC1 multifunctional scaffolding protein 
[23]. Even more interestingly, DISC1 has been linked to 
stress-induced psychosis in schizophrenic individuals [24], 
a clinical feature that is presented more frequent in patients 
harbouring specific NEDD4 genotypes [21]. It is therefore 
possible that these proteins act within the same, or related, 
signalling pathways.
NEDD4 may also fit into the presently elusive link 
between Miro proteins and cellular metabolism. Prior 
implications in the Miro GTPases with cellular metabolism 
have been limited to studies in yeast [5], so the presence 
of several proteins related to cellular metabolism is rather 
intriguing, suggesting that these roles for cellular metabo-
lism may be conserved in higher organisms. Several of 
the proteins of interest identified were involved in cellular 
metabolism, and oxidative stress has been shown to acti-
vate NEDD4 in a pathway leading to the activation of tran-
scription factors [25]. One possibility is that signalling for 
Fig. 4  Biological processes 
associated with human Miro1 
and Miro2. Overall biologi-
cal processes that are pos-
sibly mediated by differential 
expression of Miro1 and Miro2 
are shown using a histogram 
showing some distinct functions 
mediated exclusively by each 
human Miro GTPase
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excessive production of free radicals arising from oxidative 
metabolism occurs through Miro proteins to proteins such as 
NEDD4. However, this remains to be explored.
NEDD6 is perhaps less exciting, a ribosomal protein dis-
playing developmental downregulation in neuronal precur-
sor cells [26]. It presently appears to be involved in protein 
expression alone. NEDD8, however, represents an appar-
ently multifunctional ubiquitin-like protein (ULP) sharing 
∼ 60% amino acid identity with ubiquitin [27] that appears 
to possess tumour suppressive roles [28] and has been 
reported in the literature as a regulator of caspase-1 [29]. 
Additionally, NEDD8 has been shown to play crucial roles 
in endometrial function [30].
RhoC
The suggested link between RhoC and hMiro1-N18 is 
also interesting, fitting into the theme that dominant nega-
tive versions of the hMiro N-terminal GTPase domain are 
involved in a wider range of pathways than the constitu-
tively active versions. Rho proteins are typically associated 
with cytoskeletal reorganisation, although the fine-tuning of 
RhoC activity appears to particularly influence cell motility 
[31]. A link between RhoC signalling and the Miro GTPases 
therefore seems logical, in light of the cell migration results 
previously reported in studies implicating the Miros in cell 
motility and migration. Due to the primary localisation of 
RhoC at the plasma membrane [32], it is unlikely that the 
Miros directly interact with RhoC. However, these results 
indicate that hMiro1 acts downstream of the RhoC pathway 
in a manner that may be related to the GTPase state of the 
N-terminal GTPase domain.
PSMD4 and proteasomal degradation signalling 
components
The notable presence of PSMD4 was initially somewhat 
puzzling, resisting the trend of hMiro V13 mutants being 
more likely to be associated with components of the pro-
teasome complex. PSDM4 is an essential constituent of 
the 19S proteasomal regulatory complex [19, 33] respon-
sible for proteasome substrate recognition and known to 
play important roles in sperm-zona pellucida penetra-
tion during fertilisation [34]. However, while this pro-
tein is related to the Ubiquitin proteosomal system, it is 
predominantly involved in ensuring that only correctly 
labelled (ubiquitinated) proteins are processed for degra-
dation [19]. No components of the UBS directly linked 
to actual degradation were associated with hMiro N18 
mutants in this study, although several proteins related 
to ubiquitination or the sorting of ubiquitinated proteins 
were. Conversely, V13 mutants were associated with 
Fig. 5  Summary of major biological functions associated with each 
protein of interest. Biological processes association analysed for 
constitutively active Miro1 (hMiro1V13) and dominant negative 
(hMiro1N18) are given as a percentage of total protein in grey and 
orange bars. Similarly, the specific biological processes associated 
with constitutively active Miro2 (hMiro2 V13) and dominant negative 
(hMiro2 N18) are given as a percentage of total protein using blue 
and yellow bars. (Color figure online)
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both ubiquitination proteins and, in the case of hMiro2-
V13, components of the proteasome protein core directly 
involved in proteasomal degradation. Potentially, this 
could indicate that Miro proteins that are active in the 
N-terminal GTPase domain are more likely to be ubiq-
uitinated and subsequently degraded by the UBS, while 
that Miro proteins that are inactive in this domain may 
still be ubiquitinated but are more likely to be thoroughly 
checked prior to degradation. This is conjecture, however. 
The targeting of proteins for proteasomal degradation is 
complex and influenced by several signalling pathways. 
Thus, further investigation of the relationship between 
the Miro N-terminal GTPase state and propensity towards 
UBS-mediated degradation is required.
Proteins involved in endoplasmic reticulum 
signalling
Beyond RhoC, rUB-R5 and NEDD, the two hMiro2-
N18-associated proteins linked to the endoplasmic retic-
ulum (ERO1LA and calnexin), were particularly inter-
esting. ERO1LA, also known as endoplasmic reticulum 
oxidoreductase 1, pairs oxidation of thiols to the reduc-
tion of molecular oxygen to produce hydrogen peroxide 
 (H2O2) and has been implicated in cancer progression 
and immune signalling [35–37]. ERO1LA has also been 
implicated in the regulation of  Ca2+ fluxes at the inter-
face between the endoplasmic reticulum and mitochondria 
[38]. Conversely, calnexin is a calcium-binding protein 
localised to contact points between mitochondria and 
the endoplasmic reticulum, displaying roles either as a 
quality control chaperon (when non-palmitoylated) or 
a calcium signalling protein (when palmitoylated) [39]. 
Interestingly, Miro proteins have been implicated in intra-
cellular calcium buffering and have been shown to local-
ise to ER-mitochondrial contact points. Additionally, the 
yeast Miro Gem1p interacts with the ER-mitochondria 
encounter structure (ERMES). While a direct associa-
tion between Miro and ERMES in humans has not yet 
been established, the presence of Calnexin and another 
ER-related protein, ERO1A, in this study is noteworthy, 
suggesting that the hMiros indeed interact with ERMES-
like proteins at ER-mitochondria contact points [40, 41]. 
Other notable groups of proteins identified in this study 
included proteins related to protein expression, which 
were enriched across various data sources and may indi-
cate that regulation of the hMiro signalling pathways 
occurs, at least partly, at the level of expression. Whether 
the Miro proteins themselves are significantly regulated at 
the level of expression is unknown, though this phenom-
enon has been demonstrated for other atypical GTPases, 
such as the Rnd proteins and RhoH [42].
Proteins associated with neurodegeneration
Finally, the presence of several Alzheimer’s and cancer-
related proteins identified in this study are noteworthy. The 
Miro GTPases have been implicated in both neurodegenera-
tive diseases and neoplastic disorders when dysregulated. 
According to the results obtained here, the development of 
these disorders may occur in some situations through the 
GTPase status of the hMiro N-terminal GTPase domain. 
It is uncertain why an enrichment in Alzheimer’s-related 
proteins was demonstrated, but not other proteins associ-
ated with neurological disorders. While Miro inhibition has 
been linked to Alzheimer’s through activation of the PAR-1/
MARK family kinases and subsequent promotion of patho-
logical tau phosphorylation [43], links to other neurological 
disorders such as Parkinson’s and ALS are repeatedly noted 
in the literature. The enhanced presence of Alzheimer’s-
related proteins here, however, may partly reflect that Alz-
heimer’s is the most common form of dementia [44] and cor-
respondingly heavily researched. Thus, proteins implicated 
to Alzheimer’s are more likely to be labelled as such in the 
literature. Regardless, the presence of proteins implicated 
in neoplasia and Alzheimer’s disease is in congruence with 
previous reports of Miro function and the development of 
these pathologies. Too, it is quite possible that some proteins 
considered ‘Alzheimer’s-related’ actually engage in other 
neuropathological states when dysregulated [45].
Bioinformatics analysis for identifying VopE‑like 
effectors in other bacteria
Although role of mitochondria in ATP generation and 
programmed cell death has been long established, role of 
mitochondria in various innate immune responses through 
PIG-I-like signalling, antibacterial immunity and inflamma-
tion is clearly still emerging. A study using Vibrio cholerae 
AM-19226 as a model organism as recently shown a Type 3 
Secretion System (T3SS)-delivered effector VopE is required 
to prevent mitochondrial perinuclear clustering and to sup-
press innate immune responses during V. cholerae infection 
of cultured mammalian cells. This study established that 
Miro1 and Miro2 GTPases enzymatic activities are modu-
lated through VopE effector binding. This interaction was 
shown to effectively interfere with the mitochondrial activ-
ity regulated by the Miros [16]. In a different investigation, 
Miro-1 was shown to control lymphocyte migration and 
polarity through controlling the mitochondrial accumula-
tion around microtubule-organising centre in response to 
chemokines. This regulatory role of Miros over lympho-
cytes is highly significant since the lymphocyte migration 
maintaining polarity and adhesion is essential for functional 
immune response [46]. Therefore, it is becoming apparent 
that Miros play a considerable role in contributing towards 
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the immunological role of mitochondrial. Therefore as a 
first step, we tried to perform bioinformatics analysis to 
identify possible other type III or type III-like effectors that 
may be modulating host immunity via Miro GTPases. The 
BLAST search revealed the presence of gene encoding VopE 
or VopE-like proteins in other strains of Vibrio cholerae as 
well as other Gram-negative bacterial species including 
Aeromonas hydrophila, Salmonella enterica, Vibrio ichthy-
oenteri, Yersinia enterocolitica, Yersinia intermedia, Yers-
inia pestis and Yersinia pseudotuberculosis (supplementary 
Fig. 1). However, the amino acid sequence similarities var-
ied between 23.4 and 40.5% to proteins in other species.
The majority of VopE hits (88 hits; 76.5%) were from dif-
ferent serovars of Salmonella enterica that formed a distinct 
cluster in the ML tree (Fig. 6). Similarly, VopE sequences 
from all Yersinia species and Aeromonas hydrophila grouped 
together in distinct clades. These results suggest that the 
VopE sequences are quite conserved at the species level and 
variety of other serovars can harbour type III effectors that 
could modulate the Miro GTPase activity functioning as 
effectors or guanine nucleotide activating proteins.
We identified the conserved and semi-conserved regions 
in the alignment of representative sequences that were previ-
ously described by [47]. Bulge I and II regions are located 
from positions 203–215 and 246–260 in our alignment, 
respectively (Supplementary file 1). However, some of the 
conserved and semi-conserved sites have gaps in the align-
ment as the dataset analysed in this study is more diverse. 
The MTR domain required for mitochondrial targeting is 
quite diverse that includes first 92 sites in the alignment.
Materials and methods
Sample preparation
Mammalian pRK5-Myc primers harbouring point mutations 
in the hMiro1 and hMiro2 N-terminal GTPase domain were 
kindly donated by the Pontus Aspenström Group (Karolin-
ska Institutet, Sweden) (Addgene plasmid No 47888). These 
were used to overexpress hMiro1 and hMiro2 mutants ren-
dering the N-terminal GTPase domain either constitutively 
active (V13 mutants) or dominant negative (N18 mutants). 
Cells to be transfected for overexpression were plated onto 
6-well plates at 250,000 cells per well and allowed to incu-
bate at  37oC/5%  CO2 until approximately 70% confluent. 
Lipofectamine™ 2000 reagent was used for the transfec-
tion of exogenous plasmid DNA (pDNA) into mammalian 
cells according to the manufacturer’s instructions. Cells 
were allowed to incubate for 24 h prior to transfection, then 
washed twice with PBS, allowed to trypsinize for 5 min at 
 37oC/5%  CO2 in 0.25% trypsin–EDTA and harvested by 
centrifugation at 1200×g for 5 min. The cell pellet was sub-
jected to lysis on ice in RIPA buffer (25 mM TRIS pH 7.4, 
150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% 
Triton-X) supplemented with P8340 protease inhibitor cock-
tail (Sigma Aldrich, UK). Each pellet was subsequently spun 
at 15,000×g for 18 min (4 °C) and the resulting supernatant 
retained on ice. The protein concentration of each sample 
was determined using Bradford’s reagent (Sigma Aldrich, 
UK), and 20 µg of each sample loaded twice into separate 
12% SDS–PAGE gel wells, with one part of the sample 
assessed for overexpression success using anti-hMiro1 or 
anti-hMiro2 immunoblotting and the other part processed 
using the geLC-MS method described below.
Proteolytic digestion
In-gel digestion was performed as previously described. 
Briefly, 20 µg of each sample was fractionated based on 
molecular weight on a 12% SDS–PAGE gel. The frac-
tionated protein lane was cut into 8 bands and each band 
separately sliced into further small sections and placed into 
individual tubes for destaining achieved via 3 washes with 
100 μL of 100 mM ammonium bicarbonate/acetonitrile 
(1:1, vol/vol) with shaking. This solution was removed, 
Fig. 6  A maximum-likelihood 
tree derived from amino 
sequenced alignment of the 
BLAST hits (E-value ≤ 0.001 
and > 20% sequence identity) 
of Vibrio cholerae VopE protein 
in the Uniprot database. The 
scale bar represents amino acid 
substitutions per site
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and reduction performed in 200 µL 10 mM DTT (made in 
50 mM ammonium bicarbonate) at 56 °C for 60 min in a 
closed water bath. The gel fragments were allowed to cool, 
reduction solution removed and alkylation performed in 
the dark for 30 min using 200 µL 54 mM iodoacetamide 
prepared in 50 mM ammonium bicarbonate. 50 µL 100% 
acetonitrile was added to the gel fragments and allowed to 
incubate at room temperature until the gel pieces became 
white and shrunken. The acetonitrile was removed and the 
samples were subjected to drying in a centrifugal evapora-
tor (speedvac) for 15 min to encourage dissipation of latent 
acetonitrile. The gel fragments were then pre-incubated on 
ice for 60 min with 5 µg Typsin Gold (Promega) solution 
prepared in 50 mM acetic acid. 20 µL ammonium bicar-
bonate was then added to each tube to cover gel pieces and 
maintain moisture during proteolytic digestion with trypsin. 
Trypsin digestion was performed overnight at 37 °C in a 
water bath with occasional gentle shaking. After at least 
12 h, the digestion was arrested by addition of 100 µL 1:2 
(vol/vol) 5% formic acid/acetonitrile to each tube. The tubes 
were then incubated with shaking for 30 min at room tem-
perature and the supernatant retained due to the presence of 
extracted peptides. The addition of 30 µL of 0.1% (vol/vol) 
trifluoroacetic acid to each sample followed by 5-min incu-
bation ensured further peptide extraction, the supernatant 
retained once again. The resulting pooled liquid was sub-
jected to freeze-drying overnight in a Christ Alpha 1–2 LD 
Freeze Dryer, and the resulting lyophilised samples each re-
suspended in 30 µL of LC-MS Buffer A (5% acetonitrile and 
0.1% formic acid in LCMS-grade water). 6 µL of sample was 
loaded into a Chromacol vial and 3 µL injected for LC-MS.
LC‑MS/MS analysis on a Q‑Exactive™ hybrid 
quadrupole‑orbitrap mass spectrometer
The 8 fractions for each sample were subjected to LC-MS/
MS analysis on a Q-ExactiveTM Hybrid Quadrupole-Orbitrap 
Mass Spectrometer (Thermo Scientific, Bremen, Germany) 
connected to an Ultimate 3000 nano LC-MS/MS system 
(Dionex LC packings, Amsterdam, The Netherlands). Separa-
tion of peptides was accomplished with an EasySpray column 
(PepMap C18, 2 µm 100 A, 75 µm x 50 cm) maintained at 
45 °C. The peptide fractions were loaded onto the trap column 
at a flow rate of 3 ml  min− 1 using 0.1% formic acid/5% ace-
tonitrile (solvent A). The peptides were then fractionated on an 
analytical column using an LC gradient of 5–40% of solvent 
B (95% ACN, 0.1% formic acid) over a period of 120 min at a 
flow rate of 0.2 µL  min− 1. The spray voltage was set to 2.3 kV. 
Data were obtained using a data-dependent Top 10 methodol-
ogy, with scans acquired in the Orbitrap mass analyser over a 
range of 150–1500 m/z, mass resolution set to 70,000 and tar-
get value set to 1.00E + 06. The ten most intense peaks with a 
charge state of ≥ 2 were subsequently fragmented in the HCD 
collision cell and tandem mass spectra obtained in the Orbit-
rap with mass resolution set to 17,500 and target value set to 
1.00E + 05. Maximum ion accumulation times were 100 ms 
for the full MS scan and 50 ms for the tandem mass spectra. 
Polydimethylcyclosiloxane (m/z, 445.1200025) ions were used 
for internal calibration.
Data analysis
Mass spectrometry data were searched against the NCBI 
Human RefSeq 70 database, using X!Tandem and MASCOT 
search platforms. Carbamidomethylation of cysteine was set 
as a static modification, while the oxidation of methionine 
was set as a dynamic modification. Other search parameters 
included the allowance of one missed cleavage by trypsin 
and a 1% false discovery rate (FDR) at PSM level. Terms for 
biological processes and molecular functions were derived 
from NCBI RefSeq and the Human Protein Reference Data-
base (HPRD). Progenesis QI, compatible with MASCOT 
search results, was used to align ion intensity maps and 
resolve conflicts. The data obtained from proteomic analy-
sis before superimposition on bioinformatics tools were also 
analysed using progenesis software-based IMPaLA (Inte-
grated Molecular Pathway Level Analysis) online tool. For 
further analysis, data were compared to predicted interaction 
partners for hMiro1 and hMiro2 according to the STRING 
2.0 protein–protein interaction prediction database. Com-
parisons were also drawn to known interactors according 
to manual literature searches, and proteins known or pre-
dicted to interact with the closest homologues of hMiro1 and 
hMiro2 according to the STRING 2.0 database.
VopE sequence analyses using bioinformatics tools
The amino acid sequence of VopE (locus tag: A33_021662) 
was extracted from the genome of Vibrio cholerae strain 
AM-19226 (Accession number: AATY02000000). The 
sequence was BLAST searched [48] in the UniProt data-
base. The protein sequence of 115 hits with E-value ≤ 0.001 
and > 20% sequence identity (Supplementary Table 1) were 
aligned to the query sequence using CLUSTLW [49].
A maximum-likelihood (ML) tree was generated from 
this alignment following the JTT + G4 substitution model 
with 100,000 SH-aLRT (SH-like approximate likelihood 
ratio tests) and 100,000 ultrafast bootstrap iterations using 
IQ-Tree [50, 51]. The tree was visualised using iTOL [52].
Conclusions
The hMiro GTPases are important enzymes that play signifi-
cant roles in mitochondrial transport and homeostasis, and 
may be significantly involved in the development of several 
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neuropathological disorders. Proteome characterisation of the 
effects of hMiro1 and hMiro2 GTPase states on intracellular 
signalling through functional assays and validation will aid in 
the understanding of the roles of these important mitochondrial 
enzymes in health and disease conditions. However, our ini-
tial proteomic and bioinformatics analyses clearly indicate that 
there are mutually exclusive cellular processes that are medi-
ated by individual Miros. While Miro1 is seen to be mediating 
cellular function through modulation of signalling pathways 
that mediate Transport machinery components, immunologi-
cal responses, cytoskeletal reorganisation and mitochondrial 
movement, the Miro2-specific signalling mediation can be 
classified into apoptosis, Hypoxia, Ras pathway regulation 
and tyrosine phosphatase-mediated signalling cascades. A 
number of proteins involved in redox pathways and unchar-
acterised proteins with putative function are identified in this 
study for which any specific function and signalling pathway 
cannot be attributed with confidence at this stage. Scaffold 
proteins such as DLG1 or 14-3-3 proteins that are identified 
to be significantly upregulated may indicate that hMiros par-
ticipate in larger protein assemblies. Based on the domain 
architecture and previously reported functions of hMiro and 
its homologues, it is tempting to propose that hMiros may form 
a number of protein assemblies mediateing varying subcellular 
functions based on cellular statuses such as ATP requirement, 
calcium concentration or redox state of the cell. Although 
we have identified specific protein entities that could func-
tion as the effectors of these GTPase or simply interactors of 
large protein assembly in complex cellular processes it will be 
essential to experimentally validate the co-expression, binding 
or signal cascading using experimental approaches in future. 
We predict that the identification of numerous putative hMiro1 
and hMiro2 interactors and signalling pathways here will aid in 
developing a more complete picture of the range of molecular 
functions and processes associated with these enzymes, paving 
the way for future proteomic studies to help further elucidate 
Miro-related signalling pathways and their influence on health 
and pathology.
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